Remed sales accelerate in 2nd quarter
After a majority stake in its ownership was acquired by MOHS Analytics, Inc. in the last quarter of 2024, Remed Pharmaceuticals recorded accelerated sales in the first half of 2025. Sales in the first semester grew by 88 percent versus target, and 35 percent growth over the same period in 2024. Growth in the quarter…